Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 8, 2001
Activity of a novel dual thromboxane A(2)receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth musclesS Rolin, J M Dogné, C Michaux, et al.Epilepsia|March 1, 1997
Anticonvulsant activity of pyrid-3-yl-sulfonyl ureas and thioureasB Masereel, D M Lambert, J M Dogné, et al.Current Medicinal Chemistry|March 7, 2000
New trends in thromboxane and prostacyclin modulatorsJ M Dogné, X de Leval, J Delarge, et al.European Journal of Medicinal Chemistry|December 21, 2000
Isosterism among analogues of torasemide: conformational, electronic and lipophilic propertiesJ Wouters, C Michaux, F Durant, et al.Journal De Pharmacie De Belgique|April 28, 2012
[Clinical studies, the interests and limits of using dabigatran in atrial fibrillation]A Sternotte, J Douxfils, B Chatelain, et al.Acta Crystallographica. Section C, Crystal Structure Communications|October 12, 2000
Terbogrel, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibitionC Michaux, B Norberg, J M Dogné, et al.Bioorganic & Medicinal Chemistry Letters|May 1, 2001
Structure determination and comparison of BM567, a sulfonylurea, with terbogrel, two compounds with dual action, thromboxane receptor antagonism and thromboxane synthase inhibitionC Michaux, S Rolin, J M Dogné, et al.Journal of Thrombosis and Haemostasis : JTH|December 29, 2016
Inactivation of human coagulation factor X by a protease of the pathogen Capnocytophaga canimorsusK Hack, F Renzi, E Hess, et al.The Journal of Pharmacy and Pharmacology|May 24, 2001
Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitorJ M Dogné, J Wouters, S Rolin, et al.Current Medicinal Chemistry|July 27, 2000
Recent advances in inducible cyclooxygenase (COX-2) inhibitionX de Leval, J Delarge, F Somers, et al.Pageof 3